The all operations of industry are under the vigilance of drug regulatory authorities that enforce high standards, enhances efforts, build trust of its end users and the obligation on the regulatory bodies to insure a great supply of quality drugs at affordable costs.
India is the 3rd largest producer of medicines in terms volume and it is rising at a steady pace. The biopharma market has viewed the entry of many international players as well as rise of many domestic producers. After the new government formation, the biopharma sector has been given a major encouragement with the initiatives like ‘Make in India’ and ‘Swach Bharat Abhiyan’. Thus with contrives to make India a superpower and improve the biopharma market, the Government of India is on the right way for now.